P 113D
Alternative Names: P-113 pulmonary spray - Demegen; P113DLatest Information Update: 25 Feb 2008
At a glance
- Originator Demegen
- Class Amino acids; Antibacterials; Antifungals; Peptide antibiotics; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cystic fibrosis-associated respiratory tract infections
Most Recent Events
- 27 Jun 2003 Suspended - Preclinical for Cystic fibrosis-associated respiratory tract infections in USA (Inhalation)
- 05 Nov 2002 P 113D has received orphan drug status for Cystic fibrosis in USA
- 03 Apr 2002 Preclinical trials in Cystic fibrosis-associated respiratory tract infections in USA (Inhalation)